A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population
Jump to navigation
Jump to search
Target Article[edit | edit source]
A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population; S Livadas, M Dracopoulou, C Lazaropoulouae; 2009; doi_citing_unknown
Retraction[edit | edit source]
Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000
Citation piece[edit | edit source]
Note: Open to append information.